HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Intensified insulin therapy plus antineuritic medication is more effective than antineuritics alone in painful diabetic neuropathy].

AbstractBACKGROUND:
The basis of the treatment of painful diabetic neuropathy is the use of drugs that block the transmission of pain (antineuritics) and a good metabolic control of underlying disease.
AIM:
To describe the outcomes of 17 type-2 diabetics with painful neuropathy, treated between 1988 and 2005 with symptomatic therapy plus intensified insulin.
MATERIAL AND METHODS:
Review of medical records of 17 type-2 diabetic patients, aged 63+/-11 years and a duration of diabetes of 15+/-8 years. All patients received intensified insulin therapy with 0.35 units/kg of NPH insulin (2/3 before breakfast and 1/3 evening meal), plus capillary glucose measurements and regular insulin (with sliding-scale centered in approximately 0.1 units/kg) before the 3 main meals. All patients were also treated with gabapentin, nortriptyline or clomipramine. Pain was assessed using a visual analog score of 10 points.
RESULTS:
After 1 year, glycosilated hemoglobin decreased from 10.0+/-1.4% to 7.7+/-1.2% (p approximately =0.003). Pain decreased from 10 to 5.1+/-3.3 at one month, 2.3+/-3.2 at six months, and 3.1+/-3.6 at 1 year (p <0.01). There was a direct statistical correlation between the reduction of HbA1C and pain decline (r =0.736; p =0.037). Pain scores were lower than those reported elsewhere for Pregabalin (n =76; p =0.05), Lamotrigine (n =27; p <0.0005), Topiramate (n =208; p <0.005), and Gabapentin (n =84; p <0.025). The lack of difference to Sodium Valproate (n =21; p =0.07) had borderline significance.
CONCLUSIONS:
The addition of intensified insulin therapy to the symptomatic treatment of painful neuropathy in type-2 diabetics, significantly enhanced the reduction of pain. The lowering of glycosilated hemoglobin was a significant predictor of success in pain reduction.
AuthorsM Juliana Bastías A, Luis Toro C, Pablo Olmos C
JournalRevista medica de Chile (Rev Med Chil) Vol. 134 Issue 12 Pg. 1507-15 (Dec 2006) ISSN: 0034-9887 [Print] Chile
Vernacular TitleLa insulinoterapia intensificada más antineuríticos es superior a antineurítico puro en neuropatía diabética dolorosa.
PMID17277866 (Publication Type: Journal Article)
Chemical References
  • Adrenergic Uptake Inhibitors
  • Amines
  • Analgesics
  • Cyclohexanecarboxylic Acids
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin
  • gamma-Aminobutyric Acid
  • Gabapentin
  • Nortriptyline
  • Clomipramine
Topics
  • Adrenergic Uptake Inhibitors (administration & dosage)
  • Adult
  • Aged
  • Amines (administration & dosage)
  • Analgesics (administration & dosage)
  • Clomipramine (administration & dosage)
  • Cyclohexanecarboxylic Acids (administration & dosage)
  • Diabetes Mellitus, Type 2 (complications, drug therapy)
  • Diabetic Neuropathies (complications, drug therapy)
  • Drug Therapy, Combination
  • Gabapentin
  • Glycated Hemoglobin (analysis)
  • Humans
  • Hypoglycemic Agents (administration & dosage)
  • Insulin (administration & dosage)
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Neuralgia (drug therapy, etiology)
  • Nortriptyline (administration & dosage)
  • Retrospective Studies
  • gamma-Aminobutyric Acid (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: